The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis
- 23 January 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 17 (2) , 215-223
Abstract
NASH-related liver transplants are increasing because of the obesity epidemic, but the influence of T2DM on various levels of BMI among NASH recipients is unclear. We analyzed data retrieved from SRTR on 4,515 patients. We divided patients by BMI into five groups: normal weight; overweight; class 1 obesity; class 2 obesity; and class 3 obesity. Statistical analysis was done. Patients in the NASH group with T2DM had a lower patient and graft survival than patients without T2DM (5-year patient and graft survival: 77.5% vs. 79.8%; P = 0.001 and 76.4% vs. 78.2%; P = 0.002, respectively). Multivariate Cox proportional regression showed an independent association between T2DM and decreased patient and graft survival (HR, 1.170; P = 0.015 and HR, 1.133; P = 0.048, respectively). In the lean and the class 3 obesity NASH groups, patients with T2DM had lower patient and graft survival than the patients without T2DM. In the class 3 obesity NASH group, T2DM was independently associated with decreased patient survival (HR, 1.581; P = 0.027). Our research reveals that the focus of the post-transplantation treatment should be different for different BMI patients.Keywords
Funding Information
- Key Research and Development Programs of Zhejiang Province (2020C03057)
- Key Science and Technology Program of Zhejiang Province (WKJ-ZJ-1818)
- Zhejiang Province Natural Science Foundation (LQ21H030004)
This publication has 29 references indexed in Scilit:
- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLDDigestive Diseases and Sciences, 2016
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groupsDigestive and Liver Disease, 2015
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical managementJournal of Hepatology, 2015
- Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLDDiabetes Care, 2015
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hepatology, 2013
- Outcome After Liver Transplantation for NASH CirrhosisAmerican Journal of Transplantation, 2009
- Prolonged Waiting Times for Liver Transplantation in Obese PatientsAnnals of Surgery, 2008
- Effect of Body Mass Index on the Survival Benefit of Liver TransplantationLiver Transplantation, 2007
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitusLiver Transplantation, 2002